/* Hide loading templates */ #js-listings:before, #js-listings:after, .loading-page:before, .loading-page, .loading-page:after, .loading-spinner:before, .loading-spinner:after, body:not(.ember-application):before, body:not(.ember-application):after, /* Hide ui that requires scripting */ #stream_launch_widget, .btn-group { display: none !important; } /* show hidden page elements */ body>#full-page-viewport-wrapper, body>#navigation-menu { display: inherit; } /* show images */ #main img, #series img, #related img { opacity: 1; } /* style warning message */ .noscript-warning { color: #003666; margin: 0 2rem 2rem 2rem; padding: 1.5rem; background: #EBC0B7; border-radius: 5px; } It looks like there's an issue with JavaScript in your browser. For a better experience, we recommend that you enable JavaScript. Go to https://www.whatismybrowser.com/guides/how-to-enable-javascript/ to learn more.

Eric Sagara

Eric Sagara appears in the following:

4 Years Of Lessons Learned About Drugmakers' Payments To Doctors

Monday, September 29, 2014

NPR

By Charles Ornstein / Ryann Grochowski Jones / Eric Sagara

American doctors received at least $1.4 billion in payments from drug companies last year. What did the companies get for their money?

Drugmakers Slash Spending On Doctors' Sales Talks

Tuesday, March 04, 2014

NPR

By Charles Ornstein / Eric Sagara / Ryann Grochowski Jones

The sharp decline in payments coincides with increased scrutiny of drug marketing. Later this year, federal law will also require that drugmakers disclose the amount of money they give to doctors.